|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
Forget to sign up for the ASHI Networking Dinner? Add it to your confirmed registration
If you are already registered for the meeting, and forgot to sign up for the ASHI Networking Dinner, it’s easy to add. Just go to your confirmation email and scroll to the end, where the phrase “You can make changes to your registration record ... by going to:” appears, followed by a link. Click on the link and log in. Once in, you need to select “Add Option.” Then just check off the Networking Dinner and pay for your ticket.
| Share this article:
It's almost show time! That means it's time to download the FREE ASHI Mobile App!
The 40th ASHI Annual Meeting mobile app is your one-stop source for:
Download the app to create your personalized schedule and plan time for networking between sessions. Navigate and communicate at the meeting more easily than ever before! Downloading is easy. Search the App Store for:
- floor maps
- Twitter feeds
- direct messaging and more!
“ASHI 40th Annual Meeting” or ”ashi2014” or, even easier, just scan this QR code:
The ASHI Annual Meeting mobile app gives attendees comprehensive information on the meeting, including session times and locations, presenter bios, an exhibitor listing and exhibit hall map. You’ll also find information on the date and location of the race and the networking dinner.
Once you download the app, please take the time to register yourself so that you receive important alerts from ASHI and our sponsor GenDx.
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee:
Times and Dates:
Nov. 5, from 8:30 a.m.-5 p.m.
Nov. 6, from 8:30 a.m.-12 p.m.
At this meeting there will be a report from the workgroup charged with providing input to CLIAC regarding the acceptability and application of virtual cross-matching in lieu of serologic cross-matching for transplantation. Persons interested in viewing this meeting on a Webcast can access information here.
Online Registration Required: All people attending the CLIAC meeting in-person are required to register for the meeting online at least 5 business days in advance for U.S. citizens and at least 10 business days in advance for international registrants. Register here by scrolling down and clicking the link under "Meeting Registration" and completing all forms according to the instructions given.
Please complete all the required fields before submitting your registration and submit no later than Oct. 29, for U.S. registrants and Oct. 22, for international registrants.
Register now: Kidney Allocation System: Town Hall question and answer session
Thursday, Oct. 23
2–3:15 p.m. ET
The new kidney allocation system (KAS) begins Dec. 4. As a follow-up to resources that have been provided to the community in preparation for implementation of the new kidney allocation system, a question and answer session with a panel of subject matter experts will be offered to provide a venue for members to ask questions and to facilitate discussion for better understanding.
To register for the town hall, visit the website.
Genetic variants linked to rare but serious clozapine side effect
An international collaboration identifies rare variants in two human leukocyte antigen genes associated with agranulocytosis risk in people taking this antipsychotic. It almost sounds like a Zen riddle: if a medication is effective, but no one uses it, is it really a good drug? That is the conundrum facing the schizophrenia drug clozapine.
Identification of minor histocompatibility antigens by reverse immunology
Leiden University Repository
T-cell recognition of MiHA plays an important role in the GVT effect of allo-SCT. Selective infusion of T-cells reactive for hematopoiesis-restricted MiHA presented in the context of HLA-class I molecules may help to separate the beneficial GVT effects from GVHD after allo-SCT. To date, only a few MiHA that form attractive targets for adoptive immunotherapy have been characterized and the number of patients that can be treated with such MiHA-selective cell therapy remains limited.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063